Last reviewed · How we verify
Thrombosis
Approved treatments
- Coumadin · Generic (originally Wisconsin Alumni Research Foundation)
Inhibits vitamin K epoxide reductase, blocking the synthesis of vitamin K-dependent clotting factors (II, VII, IX, X) to prevent thrombosis. - Dicuman · AbbVie
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Thrombosis patent landscape — cliff calendar, originator estates, attackable patents
- Thrombosis treatment landscape brief
- Thrombosis treatment updates RSS
Frequently asked questions about Thrombosis
What drugs treat Thrombosis?
Tracked treatments include Coumadin, Dicuman.
What is the treatment for Thrombosis?
Standard treatment for Thrombosis includes Coumadin, Dicuman. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Thrombosis patent cliff · Thrombosis CI report
- Treatment: Coumadin · Generic (originally Wisconsin Alumni Research Foundation)
- Treatment: Dicuman · AbbVie
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing